AI Platform to De-risk Clinical Success

Identify targets and molecules using Generative AI, accelerating drug discovery timelines, to develop cost-effective therapies.

Leverage Validated AI Platform : We partner with companies like VedTech Bio Research Pvt. Ltd., which has a thoroughly tested AI platform for drug discovery. This platform has been utilized to assist numerous pharmaceutical companies in identifying validated targets, thereby expediting the development of therapies towards approval.

Faster Identification of Proven Pathways and Targets : Early drug discovery is one of the most leveraged use cases of Generative AI in the pharmaceutical industry. AI seamlessly integrates complex scientific, medical, chemical, and biological landscapes to help identify targets and relevant therapies at unprecedented speed and scale. Focused networks created using AI help identify crucial relationships and cause-and-effect connections for diseases and targets.

Screening of Existing Molecule Library and Design New Molecules : In addition to identifying new targets, the AI platform quickly screens De Novo molecules from existing libraries against these targets. Since comprehending the structure of targets and their activity relationship with new molecules is simpler, it also facilitates the rapid design and optimization of new molecules with minimal modifications.

Minimise Discovery and Development Duration : AI helps skip initial in-vitro experiments using in-silico methods, which helps us accelerate development and reduce overall discovery costs. AI also increases the probability of success in identifying validated targets to AI de-risk clinical success.